Grants per year
Personal profile
Research Interests
My primary clinical interest is Diabetes, especially Diabetes and Technology and the application of the use of Insulin pump Therapy and real Time Continuous glucose monitoring sensor therapy to Diabetes type 1 and Diabetes type 2. My primary research interest is Diabetes
Certifications and Licenses
| Internal Medicine | |
| Endocrinology, Diabetes & Metabolism |
Training Experience
| 1994 | Residency, Catania University, Italy |
| 2000 | Residency, Christ Hospital & Medical Center |
| 2002 | Fellowship, Univ. of Illinois Hospital |
Education/Academic qualification
MD, University of Catania
… → 1990
Research interests
- Diabetes
- Quality Improvement
Fingerprint Dive into the research topics where Grazia Aleppo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Type 1 Diabetes Mellitus
Medicine & Life Sciences
Glucose
Medicine & Life Sciences
Phosphatidylinositols
Medicine & Life Sciences
Hypoglycemia
Medicine & Life Sciences
Hydrolysis
Medicine & Life Sciences
Dihydroergocryptine
Medicine & Life Sciences
Excitatory Amino Acids
Medicine & Life Sciences
Glutamate Receptors
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2014 2024
Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients with Type 1 Diabetes
1/10/20 → 1/10/23
Project: Research project
Glycemic Profiles and Pregnancy Outcomes Study (GLOSS)
Grobman, W. A., Aleppo, G., Szmuilowicz, E. D. & Yee, L. M.
National Institute of Diabetes, Digestive and Kidney Diseases
9/20/19 → 7/31/24
Project: Research project
Gestational Diabetes
Pregnancy Outcome
Outcome Assessment (Health Care)
Mothers
Glucose
Prot#PTL-902822: Continuous Glucose MOnitoring in T2D Basal InsuLin UsErs: The MOBILE Study
3/6/19 → 3/6/22
Project: Research project
Research Output 1990 2019
Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network
McGill, J. B., Wu, M., Pop-Busui, R., Mizokami-Stout, K., Tamborlane, W. V., Aleppo, G., Gubitosi-Klug, R. A., Haller, M. J., Willi, S. M., Foster, N. C., Zimmerman, C., Libman, I., Polsky, S. & Rickels, M. R., Oct 2019, In : Journal of Diabetes and Its Complications. 33, 10, 107400.Research output: Contribution to journal › Article
Albuminuria
Kidney Diseases
Biological Factors
Type 1 Diabetes Mellitus
Diabetic Nephropathies
Cheiroarthropathy: A common disorder in patients in the T1D exchange
T1D Exchange Clinic Network, Feb 2019, In : Endocrine Practice. 25, 2, p. 138-143 6 p.Research output: Contribution to journal › Article
Type 1 Diabetes Mellitus
Upper Extremity
Registries
Dupuytren Contracture
Bursitis
3
Citations
(Scopus)
Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation
Aleppo, G. & Webb, K., Jul 1 2019, In : Journal of Diabetes Science and Technology. 13, 4, p. 664-673 10 p.Research output: Contribution to journal › Review article
Glucose
Monitoring
Office Visits
Insulin
Physiologic Monitoring
Glucose Management Indicator (GMI): A new term for estimating A1C from continuous glucose monitoring. Diabetes care 2018;41:2275–2280
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., Riddlesworth, T. D. & Cefalu, W. T., Feb 1 2019, In : Diabetes care. 42, 2, p. E29-E30Research output: Contribution to journal › Comment/debate
Glucose
34
Citations
(Scopus)
Glucose management indicator (GMI): A new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., Riddlesworth, T. D. & Cefalu, W. T., Nov 1 2018, In : Diabetes care. 41, 11, p. 2275-2280 6 p.Research output: Contribution to journal › Review article
Glucose
Names
Reading
Diabetes Complications
United States Food and Drug Administration